Statement of Sackler Family Defendants in Response to the NY Attorney General Amended Complaint

The following statement is for attribution to a spokesperson for the Sackler family defendants named in the New York Attorney Generals amended complaint.

Expanding this baseless lawsuit to include former directors of Purdue Pharma is a misguided attempt to place blame where it does not belong for a complex public health crisis. We strongly deny these allegations, which are inconsistent with the factual record, and will vigorously defend against them.

Purdue Pharma manufactures an FDA-approved medicine that represents a tiny portion of the opioid market “ never more than four percent of nationwide opioid prescriptions and currently less than two percent “ while providing life-changing relief for millions of pain patients who need it.

We have always acted properly and are committed to supporting solutions that save lives by preventing addiction and abuse of prescription medicines and treating those who are suffering from addiction. That is why we are voluntarily contributing $75 million to the ground-breaking National Center for Addiction Studies and Treatment, announced earlier this week in Oklahoma.

Solving this complex public health crisis will require collaboration and focus on the real problems our nation needs to address. Government data makes clear that the opioid crisis is growing rapidly because of illicit fentanyl smuggled in from China and Mexico “ and headline-seeking lawsuits like this only distract from the important task of identifying real solutions to that crisis.

WANT TO BUILD A FINANCIAL EMPIRE?

Subscribe to the Global Banking & Finance Review Newsletter for FREE
Get Access to Exclusive Reports to Save Time & Money

By using this form you agree with the storage and handling of your data by this website. We Will Not Spam, Rent, or Sell Your Information.
All emails include an unsubscribe link. You may opt-out at any time. See our privacy policy.

Ellen Davis/Bob Rendine
Sard Verbinnen & Co
212-687-8080
[email protected]

Clio
Boele
Goldin Solutions
212-319-3451 x650
[email protected]